av/enochian-biosciences--big.svg

COM:ENOCHIANBIO

Renovaro Biosciences

  • Stock

USD

Last Close

0.70

04/08 19:58

Market Cap

45.38M

Beta: -

Volume Today

87.29K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
average inventory
average payables
1.05M
-
927.54K
12.04%
738.39K
20.39%
672.69K
8.90%
565.72K
15.90%
456.72K
19.27%
861.21K
88.57%
3.35M
288.91%
7.37M
120.13%
average receivables
351.72K
-
459.60K
30.67%
173.32K
62.29%
71.83K
58.56%
11.39K
84.15%
1.81K
84.10%
820
54.72%
554.12K
-
book value per share
0.46
-
-0.07
114.40%
0.12
286.89%
7.11
5,586.50%
4.61
35.13%
3.59
22.14%
3.70
3.18%
1.38
62.67%
0.83
40.22%
1.37
65.91%
capex per share
-0.00
-
-0.02
1,295.76%
-0.00
79.14%
-0.00
73.97%
-0.00
90.53%
0.00
639.11%
0.00
38.28%
capex to depreciation
-0.01
-
-9.99
95,127.86%
-1.70
83.00%
-0.12
92.65%
-0.04
66.60%
0.26
728.82%
0.58
120.31%
capex to operating cash flow
0.01
-
0.08
1,118.20%
0.02
79.06%
0.00
86.55%
0.00
86.18%
-0.00
871.57%
-0.01
153.86%
capex to revenue
cash per share
0.40
-
0.00
99.39%
0.32
13,009.54%
0.71
121.28%
0.33
54.00%
0.19
42.61%
0.44
133.41%
0.17
60.14%
0.03
80.92%
0.00
93.12%
days of inventory on hand
days payables outstanding
1.14K
-
82.00K
7,089.74%
17.03K
-
28.30K
66.14%
days sales outstanding
5.93K
-
debt to assets
0.02
-
0.12
519.36%
0.46
291.17%
0.04
-
0.04
9.45%
0.08
115.01%
0.08
0.49%
0.02
81.79%
debt to equity
0.03
-
-0.16
662.34%
1.36
944.73%
0.05
-
0.04
8.23%
0.10
130.84%
0.10
7.05%
0.02
82.04%
dividend yield
earnings yield
-0.05
-
-0.07
38.19%
-0.10
41.01%
-0.13
22.37%
-0.15
19.36%
-0.06
60.61%
-0.11
93.01%
-1.12
881.51%
-1.24
11.17%
-0.54
56.82%
enterprise value
42.09M
-
23.91M
43.19%
21.45M
10.28%
57.24M
166.81%
155.20M
171.13%
193.94M
24.96%
221.07M
13.99%
99.22M
55.12%
35.62M
64.10%
153.71M
331.51%
enterprise value over ebitda
-17.70
-
-11.42
35.47%
-8.14
28.74%
-10.87
33.57%
-14.31
31.63%
-16.48
15.19%
-9.61
41.69%
-4.39
54.29%
-1.83
58.39%
-1.93
5.73%
ev to operating cash flow
-20.69
-
-16.24
21.51%
-18.22
12.18%
-13.19
27.58%
-18.24
38.26%
-18.54
1.64%
-10.73
42.15%
-6.31
41.20%
-3.03
52.03%
-14.01
363.10%
ev to sales
559.11
-
free cash flow per share
-0.27
-
-0.15
43.06%
-0.10
37.84%
-0.20
107.41%
-0.25
23.37%
-0.23
6.47%
-0.44
90.66%
-0.30
31.60%
-0.21
29.97%
-0.11
45.32%
free cash flow yield
-0.05
-
-0.06
36.66%
-0.05
18.22%
-0.06
18.70%
-0.06
8.16%
-0.05
0.92%
-0.09
61.50%
-0.16
76.14%
-0.37
138.36%
-0.07
80.12%
graham net net
0.17
-
-0.10
160.28%
0.09
190.37%
-0.37
502.88%
0.15
139.96%
-0.07
145.98%
0.12
279.50%
-0.05
144.58%
-0.18
226.04%
-0.31
77.31%
graham number
1.82
-
0.52
71.20%
0.74
41.52%
8.17
1,002.70%
8.33
1.99%
4.48
46.20%
6.87
53.33%
8.20
19.29%
3.62
55.81%
5.08
40.40%
income quality
0.86
-
0.85
1.11%
0.49
42.00%
0.47
3.67%
0.47
0.39%
0.92
94.02%
0.77
15.82%
0.14
82.02%
0.30
113.93%
0.14
54.15%
intangibles to total assets
0.04
-
0.16
338.16%
0.03
82.35%
0.91
3,213.10%
0.93
1.60%
0.94
0.99%
0.88
6.07%
0.87
1.45%
0.93
7.58%
0.98
4.91%
interest coverage
-28.73
-
-897.18
3,022.66%
-100.93
88.75%
-57.02
43.50%
-255.58K
448,101.73%
-114.34
99.96%
-61.65
46.09%
-311.33
405.03%
-54.54
82.48%
-80.73
48.01%
interest debt per share
0.02
-
0.01
55.12%
0.17
1,462.63%
0.01
96.21%
0.00
99.98%
0.17
14,491,516.87%
0.16
1.74%
0.14
13.72%
0.10
30.30%
0.04
63.31%
inventory turnover
invested capital
0.03
-
-0.16
662.34%
1.36
944.73%
0.05
-
0.04
8.23%
0.10
130.84%
47.26M
48,908,736,064.22%
132.80M
181.02%
market cap
45.00M
-
23.83M
47.04%
23.31M
2.21%
72.84M
212.54%
167.48M
129.92%
195.05M
16.46%
234.42M
20.18%
101.38M
56.75%
31.90M
68.53%
150.15M
370.64%
net current asset value
3.29M
-
-775.75K
123.59%
1.21M
255.91%
-8.00M
761.67%
5.72M
171.45%
-2.89M
150.52%
5.96M
306.22%
-2.45M
141.11%
-9.23M
277.07%
-29.15M
215.76%
net debt to ebitda
1.22
-
-0.04
103.11%
0.70
1,949.77%
2.96
321.76%
1.13
61.78%
0.09
91.65%
0.58
514.05%
0.10
83.56%
-0.19
299.97%
-0.04
76.51%
net income per share
-0.32
-
-0.18
42.42%
-0.20
7.17%
-0.42
113.83%
-0.67
60.35%
-0.25
62.82%
-0.57
127.85%
-2.16
281.15%
-0.71
67.34%
-0.84
18.81%
operating cash flow per share
-0.27
-
-0.15
43.06%
-0.10
37.84%
-0.20
105.99%
-0.23
14.58%
-0.23
0.35%
-0.44
93.56%
-0.30
31.46%
-0.21
30.13%
-0.11
45.53%
payables turnover
0.32
-
0.00
98.61%
0.02
-
0.01
39.81%
receivables turnover
0.06
-
research and ddevelopement to revenue
18.80
-
return on tangible assets
-0.47
-
-2.36
403.15%
-0.54
76.95%
-0.57
5.61%
-1.89
228.15%
-1.00
47.15%
-1.16
16.21%
-9.97
760.90%
-9.90
0.74%
-21.40
116.22%
revenue per share
0.00
-
roe
-0.68
-
2.72
499.85%
-1.56
157.35%
-0.06
96.24%
-0.15
147.17%
-0.07
52.25%
-0.15
120.82%
-1.56
920.93%
-0.85
45.37%
-0.61
28.39%
roic
-0.63
-
3.13
596.52%
-0.71
122.74%
-0.05
92.73%
-0.09
70.97%
-0.07
22.61%
-0.13
85.30%
-1.44
1,030.77%
-0.76
46.71%
-0.61
20.59%
sales general and administrative to revenue
31.02
-
shareholders equity per share
0.46
-
-0.07
114.40%
0.12
286.89%
7.11
5,586.50%
4.61
35.13%
3.59
22.14%
3.70
3.18%
1.38
62.67%
0.83
40.22%
1.37
65.91%
stock based compensation to revenue
tangible asset value
3.30M
-
-773.14K
123.46%
1.41M
282.16%
-7.84M
656.52%
6.54M
183.48%
-269.06K
104.11%
8.13M
3,122.74%
-636.42K
107.83%
-7.79M
1,123.81%
-27.38M
251.58%
tangible book value per share
0.44
-
-0.08
118.46%
0.11
241.57%
-0.36
411.14%
0.17
148.77%
-0.01
103.33%
0.17
3,069.13%
-0.01
107.03%
-0.14
1,042.52%
-0.28
105.53%
working capital
3.29M
-
-775.75K
123.59%
1.21M
255.91%
14.89M
1,130.98%
11.38M
23.53%
7.61M
33.19%
19.01M
149.96%
3.11M
83.62%
-8.46M
371.59%
-28.31M
234.75%

All numbers in USD (except ratios and percentages)